Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Suitability is determined by a doctor following clinical evaluation, and the mention of this technology does not imply that any specific treatment is recommended
Are you feeling stressed and overwhelmed
continued 5.5% additional loss in tirzepatide continuation group SURMOUNT-4: Weight maintenance trial confirming sustained benefits over extended treatment [1] November 2023: FDA Approval for Obesity Zepbound (tirzepatide) approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with weight-related comorbidities
The 180-capsule bottles of each are more reasonable but still significantly higher than any of the others, at $1.17 and $1.50 per day
Pregnancy and nursing are practical contraindications due to lack of safety data
Clinical trials show semaglutide produces an average body weight reduction of 15% or more, and tirzepatide produces reductions exceeding 20% in some populations
US$ 26.81
US$ 25.07
US$ 26.12
US$ 20.33
US$ 20.07
US$ 26.54
US$ 22.36
US$ 23.61
US$ 26.63
US$ 25.08
US$ 27.91
US$ 25.89
